News and Events

Urology Update 2016

Urology Update 2015

Urology Update 2016
Canada’s Premier Urology CPD Conference

November 11 – 12, 2016 – The Westin Harbour Castle Toronto

This seminar will provide an in-depth update of various topics in clinical urology. New developments will be presented by world-renowned experts in their fields. All of the lectures will be supplemented with discussions, case presentations and audience participation. Participants will gain an understanding of the new developments and have a balanced view of various alternatives. Participants will increase their knowledge in these areas to facilitate management of clinical problems.


  • Prostate Cancer
  • Upper tract urothelial cancer
  • Renal cell carcinoma
  • Urinary incontinence
  • Overactive bladder
  • Male sexual dysfunction
  • Pediatric topics
  • Use of analgesics in urology

For complete event details and registration, visit

Astellas Prostate Cancer Innovation Grant Competition 2016-17

The University of Toronto has partnered with Astellas Pharma to create the Astellas Prostate Cancer Innovation Fund with the purpose of supporting and advancing prostate cancer research.

Under the direction and supervision of an interdisciplinary UofT review committee, overseen by the Chair of the Division of Urology, the Fund will provide 3 grants in the amount of $50,000. Grants are open to faculty members in the Faculty of Medicine and across UofT’s affiliated hospitals and research institutes, with academic appointment to the following Departments: Surgery; Medicine; Laboratory Medicine & Pathobiology; Radiation Oncology; or Medical Imaging. Please see attached for the formal Call for Applications and Terms of Reference.

Call for Applications 2016-2017

Terms of Reference 2016-2017

Inaugural “Astellas Innovation in Prostate Cancer Research” Grant Awards

Inaugural Astellas Innovation Grants in Prostate Cancer Research have been awarded to:

Dr. Tony Finelli
“Measuring the quality of care, long-term outcomes, and health care utilization in low risk prostate cancer (PC) patients undergoing active surveillance: a population-based approach”.

Dr. Shabir Alibhai
“Prescribing a reduction of sedentary time to improve cancer-related fatigue in men with prostate cancer”.

Dr. Andrei Drabovich
“Non-invasive diagnosis of prostate cancer and stratification of its molecular subtypes using genomic profiling of circulating tumor cells isolated from semen”.

Dr. Neil Fleshner
“Prostate biopsy avoidance using combination PCA3 and multiparametric magnetic resonance scanning in selected patient cohorts”.